Blood Flow Restriction in Older Adults
1 other identifier
interventional
18
1 country
1
Brief Summary
Introduction. From the age of 80 onwards, more than 50% of people suffer from sarcopenia. The loss of muscle strength leads to a loss of muscle power, impairing functionality and preventing the correct performance of activities of daily living. Objective. To analyse the efficacy of blood flow restriction in older adult patients by evaluating changes in the variables muscle power and strength, physical condition and functionality of the lower limbs. Material and method. Randomised single-blind clinical study. Thirty-six older adults will be recruited and randomised to the experimental and control groups. The intervention will have a duration of 4 weeks, with 2 weekly sessions. The intervention will consist of an intervention by performing 3 quadriceps strength exercises, with a 40% restriction. The primary variable of the study will be muscle power (Sit To Stand 5 times) and the secondary variables will be muscle strength (dynamometry), physical condition (Timed Up and Go) and functionality and autonomy (Barthel index)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2025
CompletedStudy Start
First participant enrolled
March 12, 2025
CompletedFirst Posted
Study publicly available on registry
April 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2025
CompletedApril 4, 2025
February 1, 2025
1 month
March 11, 2025
April 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline muscle power after treatment and at four weeks
Muscle power will be assessed with the Sit To Stand 5 times. This tool consists of getting up and sitting down from a chair five times. This instrument has shown high reliability (CCI= 0.95). The unit of measurement is time in seconds, where the shorter the time the greater the muscle power
Screening visit, within the first seven days after treatment and four weeks follow-up visit
Secondary Outcomes (3)
Change from baseline muscle strength after treatment and at four weeks
Screening visit, within the first seven days after treatment and four weeks follow-up visit
Change from baseline physical condition after treatment and at four weeks
Screening visit, within the first seven days after treatment and four weeks follow-up visit
Change from baseline functionality after treatment and at four weeks
Screening visit, within the first seven days after treatment and four weeks follow-up visit
Study Arms (2)
Blood flow restriction
EXPERIMENTALAn exercise protocol will be applied to work on lower limb strength in extension, with the application of BFR, with two 30-minute sessions per week for four weeks. The exercise protocol, based on previous studies in older adults, will consist of three exercises: climbing on a step, knee extension from a seated position and sitting down and getting up from a chair.
No intervention
NO INTERVENTIONPatients included in the control group will not receive any intervention, maintaining their activities of daily living in the same way as before the study.
Interventions
The intensity of the work will be set at around 40% of the maximum intensity that can be executed in a single repetition (1RM). To reach the established intensity, weights, weighted ankle supports and rubber bands of different resistances will be used. Three sets of 8-10 repetitions will be performed with breaks of 1-2 seconds between repetitions and 2-3 minutes between sets. The intensity of the work will be established by applying the rate of perceived exertion. A blood flow restriction device will be used (Akrafit, Valencia, Spain model).
Eligibility Criteria
You may qualify if:
- Older adults aged 65 to 80 years
- Independent for standing and walking with the help of assistive devices such as cane and walker
- Both genders
- Normotensive or hypertensive with controlled BP (systolic blood pressure \<140 mmHg)
- Sign the informed consent form.
You may not qualify if:
- People dependent for the performance of activities of daily living.
- People with cognitive impairments that limit the performance of the intervention or assessments.
- Persons undergoing total hip or knee arthroplasty
- Persons receiving physiotherapy treatment at the time of the study
- History of deep vein thrombosis (DVT) or pulmonary embolism
- History of myocardial infarction or stroke
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad Católica San Antonio de Murcia
Murcia, Spain
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 11, 2025
First Posted
April 2, 2025
Study Start
March 12, 2025
Primary Completion
April 13, 2025
Study Completion
April 15, 2025
Last Updated
April 4, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share